7666 — Metis TechBio Cashflow Statement
0.000.00%
Last trade - 00:00- HK$13.74bn
- HK$13.89bn
- CNY105.00m
Annual cashflow statement for Metis TechBio, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -582 | -499 | -392 |
| Depreciation | |||
| Non-Cash Items | 302 | 231 | 210 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 47 | -11.2 | 22.5 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -192 | -239 | -122 |
| Capital Expenditures | -56.5 | -3.63 | -19 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -348 | 82.6 | 54.1 |
| Sale of Fixed Assets | |||
| Change in Net Investments | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -405 | 78.9 | 35.1 |
| Financing Cash Flow Items | -522 | 0 | 13.8 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 800 | 143 | 369 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 197 | -3.83 | 271 |